UTERINE LEIOMYOSARCOMA: About 13 Cases and Review of the Literature
10.15520/jmbas.v6i12.172
Resumo
The uterine leiomyosarcoma (LMS) is a rare cancer arising from the smooth myometrial cells. The LMS is clinically
aggressive malignancy, accounting for 2% to 6% of uterine malignancies and a very low annual incidence.
Object of the study: To evaluate management and outcome of the treatment of uterine leiomyosarcoma.
Patients and methods: Retrospective study of a series of 13 patients treated for uterine leiomyosarcoma in the
department of radiotherapy of CHU Hassan II, Fes between 2012 and 2016
Results: The condition is rarely suspected preoperatively, diagnosis is usually made on histological examination of
the operative specimen. The outcome is related to the mitotic activity of the tumour and to the infiltration of nearly
structures. Surgery is the only effective treatment, chemotherapy is ineffective, adjuvant radiotherapy improves local
control of the tumour but has no incidence on survival.
Conclusion: In the absence of an effective adjuvant treatment, uterine leiomyosarcoma bears a poor prognosis with
the only exception of small non infiltring tumours with a low mitotic activity.
How to Cite
TERRAB FZ, ALLOUCH F., GHAMAD S., BOUHAFA T., ALAMI Z., HASSOUNI K. (2018). UTERINE LEIOMYOSARCOMA: About 13 Cases and Review of the Literature. Journal of Medical Biomedical and Applied Sciences , v. 6 n. 12 (2018) , 193-196 . https://doi.org/10.15520/jmbas.v6i12.172